Trials / Unknown
UnknownNCT00742352
PET FDG Assessment of Change in Atherosclerotic Plaques After Chemotherapy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Tel-Aviv Sourasky Medical Center · Other Government
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether chemotherapy induces regression in atherosclerotic plaques in oncologic patients already undergoing PET FDG as part of their routine assessment.We will use PET FDG to assess whether the inflammation in atherosclerotic plaques is affected by chemotherapy and anti angiogenic therapy.
Conditions
Timeline
- Start date
- 2008-09-01
- First posted
- 2008-08-27
- Last updated
- 2008-09-09
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00742352. Inclusion in this directory is not an endorsement.